Long-term data from a trial of adjuvant denosumab in patients with breast cancer suggest a survival benefit in addition to reduced fractures and increased bone density.
In an online poll over use of chemotherapy for premenopausal patients with early breast cancer, votes were split without consensus; debate on this issue continues.
COVID-19 Collection thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.
The phase 3 PALLAS trial assigned patients with stage II to III HR-positive, HER-negative breast cancer to adjuvant endocrine therapy with or without palbociclib.